Extract from the rheumatoid arthritis therapy at the American Collage of Rheumatology - 2004 2004 - Ameri̇kan ulusal romatoloji̇ kongresi̇nde romatoi̇d artri̇t tedavi̇si̇nden alintilar
Nobel Medicus, cilt.1, sa.2, ss.8-11, 2005 (Scopus)
- Yayın Türü: Makale / Derleme
- Cilt numarası: 1 Sayı: 2
- Basım Tarihi: 2005
- Dergi Adı: Nobel Medicus
- Derginin Tarandığı İndeksler: Scopus
- Sayfa Sayıları: ss.8-11
- Anahtar Kelimeler: Biologic therapy, Cytokine, Rheumatoid arthritis
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Annual Congresses of American Collage of Rheumatology (ACR) are the meetings that give guidance totle rheumatologists for the new therapeutic and diagnostic methods. Discussions on therapy of rheumatoid arthritis (RA) with biologic agents took the biggest part of the last 2004 ACR meeting. New biologic agents such as abacept, AMG 714, etc. which currently are not used in clinical practice gave hope for the future. However, there were new approaches for the classical drugs such as nonsteroid antiinflammatory drugs, mainly meloxicam. It has been shown that response to the methotrexate therapy can be observed by using polyglutamates. On the other hand, some studies have shown that leflunomide is not so innocent drug as it has already been thought. Presence of these many studies on RA treatment presented in ACR-2004 showed the existence of both a big effort on this area and lots of unknown.